Order Article Reprints

AbdElmoniem N, H. Abdallah M, M. Mukhtar R, Moutasim F, Rafie Ahmed A, Edris A, Ibraheem W, Makki AA, M. Elshamly E, Elhag R, et al. Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies. Molecules. 2023; 28(4):1771. https://doi.org/10.3390/molecules28041771

AbdElmoniem, Nihal, Marwa H. Abdallah, Rua M. Mukhtar, Fatima Moutasim, Ahmed Rafie Ahmed, Alaa Edris, Walaa Ibraheem, Alaa A. Makki, Eman M. Elshamly, Rashid Elhag, and et al. 2023. "Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies" Molecules 28, no. 4: 1771. https://doi.org/10.3390/molecules28041771

AbdElmoniem, N., H. Abdallah, M., M. Mukhtar, R., Moutasim, F., Rafie Ahmed, A., Edris, A., Ibraheem, W., Makki, A. A., M. Elshamly, E., Elhag, R., Osman, W., A. Mothana, R., & Alzain, A. A. (2023). Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies. Molecules, 28(4), 1771. https://doi.org/10.3390/molecules28041771